Attuali Orientamenti Nella Terapia Del Carcinoma Prostatico

Béland G. , Elhilali M. , Ftadet Y. , Laroche B. , Ramsey E. W. : Total androgen suppression in the treatment of metastatic prostate cancer. 2nd Intern. Symp. on Prostate Cancer, Paris June 1986. Alan Liss, New York (in stampa).

Bracci U. , Di Silverio F. : Il cancro della prostata: nostro attuale orientamento terapeutico. Progr. Med., 29; 779–790 (1973).

Byar D. P. : The VACURG studies of cancer of the prostate. Cancer, 32; 1126–1130 (1973).

Geller I. , Albert J. , Loza D. : DHT concentrations in human prostate cancer tissue. J. Clin. Endocr. Metab., 46; 440–444 (1978).

Gordon W. W. , Kiely E. , Kapadie R. : Combined endocrine therapy for newly diagnosed advanced prostatic cancer, p. 36, 224. Abstract. 7th Congr. E.A.U., Budapest June 1986.

Huggins C. , Hodges C. V. : Studies on prostatic cancer. The effect of castration, estrogens and androgens injections on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res., 1; 293–302 (1941).

Jacobi G. H. , Altwein J. , Kurth K. , Hohenfellner R. : Treatment of advanced prostatic cancer with parenteral cyproterone acetate: a phase III randomized trial. Brit. J. Urol., 52; 208–212 (1980).

Jordan W. P. , Blackard C. E. , Byar D. P. : Reconsideration of orchiectomy in the treatment of advanced prostatic cancer. South. Med. J., 70; 1411–1416 (1977).

Keyes E. L. , Ferguson R. S. : Textbook of Urology, p. 425. Saunders, 1936.

Labrie F. , Wenderoth U. K. : A new approach to the treatment of prostatic cancer: Buserelin (Suprefact). Excerpta Medica, 1985 (in stampa).

Lunglmayr G. , Girsch E. , Bieglmaier C. : Acceptability of orchidectomy versus GNRH agonists in the management of advanced cancer of the prostate. J. Endocr. Inv., 10; Suppl. 2, 20 (1987).

Oesterling J. E. , Epstein J. I. , Walsch P. : The inability of adrenal androgens to stimulate the adult human prostate: an autopsy evaluation of men with hypogonadotropic hypogonadism and panhypopituitarism. J. Urol., 136; 1030–1034 (1986).

Menon M. , Walsch P. : Hormonal therapy for prostatic cancer. Prostatic Cancer, Murphy G. P. (ed.), p. 175–180. P.S.G. Pub. Co. 1979.

Paulson D. F. : The role of endocrinotherapy in the management of prostate cancer. Genito-Urinary Cancer, Skinner D. G. , De Kernion J. (eds.), p. 388–413. Saunders, 1978.

Sciarra F. , Sorcini G. , Di Silverio F. , Gagliardi V. : Plasma testosterone and androstenedione after orchiectomy in prostatic adenocarcinoma. Clin. Endocrinol., 2; 101–106 (1973).

Smith J. A. , Middleton R. G. : Clinical management of prostatic cancer. Year Book Med. Pub., 134–153 (1987).